TrialPharmacoEconomics2003

Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophy.

Hiske E M van Dieten et al.PubMed ↗Publisher ↗

No numbers read from the abstract.